基本信息
views: 25
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Jennifer Lyons, PhD, MPH, is a Research Scientist in the Therapeutics and Infectious Disease Epidemiology group at the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. She works on the FDA-sponsored Sentinel Initiative for drug safety surveillance.
Research Interests
Papers共 180 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Drug Safetypp.1-10, (2024)
Mayura Shinde,Austin Cosgrove,Jennifer G. Lyons,Maria E. Kempner,Jolene Mosley,David Cole, Emma Hoffman,Elizabeth Messenger-Jones,José J. Hernández-Muñoz,Danijela Stojanovic, Benedict H. W. Wong,Yueqin Zhao,
crossref(2024)
Neurologyno. 17_supplement_2 (2023)
Pharmacoepidemiology and drug safetyno. 10 (2023): 1178-1183
The Journal of asthma : official journal of the Association for the Care of Asthmano. 7 (2023): 653-662
PHARMACOEPIDEMIOLOGY AND DRUG SAFETYno. 2 (2023): 158-215
Journal of the American Academy of Child & Adolescent Psychiatryno. 10 (2023): S305-S306
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRYno. 10 (2023): S305-S306
J. Lyons,G. K. Harada,J. Yeakel, M. Cho,F. Dayyani, B. Smith, S. Daly,N. Nguyen,H. Keshava,J. V. Kuo,S. N. Seyedin
Liesel Dsilva,Kerry McCarthy,Jennifer Lyons, Bernadette Cabigas,Nolan Campbell,George Kong, Bryan Adams,Robert Kuhelj,Priya Singhal,Karen Smirnakis
Expert opinion on drug safetyno. 10 (2023): 995-1002
Load More
Author Statistics
#Papers: 182
#Citation: 2976
H-Index: 29
G-Index: 50
Sociability: 7
Diversity: 3
Activity: 18
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn